Accolade Inc
NASDAQ:ACCD
Accolade Inc
Tax Provision
Accolade Inc
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
Tax Provision
$3.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Tax Provision
-$220.1m
|
CAGR 3-Years
11%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Tax Provision
-$249m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
7%
|
|
CVS Health Corp
NYSE:CVS
|
Tax Provision
-$2.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
|
Cigna Corp
NYSE:CI
|
Tax Provision
-$141m
|
CAGR 3-Years
61%
|
CAGR 5-Years
32%
|
CAGR 10-Years
15%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Tax Provision
-$193.7m
|
CAGR 3-Years
39%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
See Also
What is Accolade Inc's Tax Provision?
Tax Provision
3.6m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Tax Provision amounts to 3.6m USD.
What is Accolade Inc's Tax Provision growth rate?
Tax Provision CAGR 1Y
-36%
Over the last year, the Tax Provision growth was -36%.